from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0416/thiS

LFCtreatmentdescriptionclass of inhibitor

-0.508

Amikacinug/mL Amikacintranslation

-1.051

Cap5-10ug/mL Capreomycintranslation

0.073

Rox10-50 ug/mL Roxithromycintranslation

0.506

SM2-5 ug/mL Streptomycintranslation

1.692

Tet5-10 ug/mL Tetracyclinetranslation

1.002

Rif0.2-5ug/mL Rifampicintranscription

-0.020

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.354

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.409

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.318

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.447

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.370

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.545

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.681

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.328

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.768

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.877

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.213

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.173

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.025

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.747

KCN5-20 ug/mL Potassium cyaniderespiration

-3.103

NaN30.2-2 mM Sodium aziderespiration

-0.398

Nigericin50 uM Nigericinrespiration

0.158

TRC10-150 ug/mL Triclosanrespiration

-0.110

TRZ10-25 ug/mL Thioridazinerespiration

0.286

Valinomycin0.5-10 uM Valinomycinrespiration

-2.044

ZnSO42 mM ZnSO4respiration

0.627

menadione6-10 ug/mL Menadionerespiration

-0.363

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.168

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.217

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.829

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.183

NRP_1Non-replicating persistence stage 1dosRassociated

-0.398

Amp0.2mg/mL AmpicillincellWall

-0.694

Cephalexin20-100 ug/mL CephalexincellWall

-0.221

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.376

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.181

EMB10-20 ug/mL EthambutolcellWall

-0.164

Eta12-40 ug/mL EthionamidecellWall

-0.084

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.063

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.703

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.483

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.199

BZA0.12 mg/mL BenzamidearomaticAmides

0.761

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.949

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.048

H2O24 mM hydrogen peroxideDNAdamaging

-0.087

Levo10 ug/mL LevofloxacinDNAdamaging

0.528

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.190

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.157

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.727

UVUV-irradiationDNAdamaging

0.603

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.465

Antimycin12.5-50 ug/mL Antimycin A?

-0.313

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.830

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.154

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.094

PA8240.2-2 ug/mL PA-824?

-0.472

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.247

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.919

Verapamil50 uM Verapamil?

-0.668

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.034

methoxatin10-20 ug/mL Methoxatin?